Anushree has been with Abbott since 2021 and currently serving as Head of Strategy and Portfolio
This partnership encompasses dossier licensing, bulk product supply, and the licensing of ZIM Labs’ proprietary Oral Thin Film technology platform, ThinOral
Investment includes biotech agreements with Harbour BioMed, Syneron Bio and BioKangtai
Amexel aims to generate revenue through facilitation services and a profit-sharing model linked to the commercialization of products
The brand Magtein by Threotech has a sales value of approximately US $438 million
Usage of Synaffix GlycoConnect, HydraSpace and toxSYN ADC technologies to enhance efficacy, tolerability and target engagement
The biosimilar Ustekinumab has been developed and manufactured by the company
The TGA approval marks a pivotal step in Rusan Pharma’s expansion into the Australian market
The inspection scope had included six separate Biologics manufacturing units comprising of four Drug Substance and two Drug Product manufacturing plants
Revenue at Rs 3,623 crore, EBITDA at Rs 718 crore
Subscribe To Our Newsletter & Stay Updated
